Alume Biosciences

La Jolla, CA · Founded 2017 · Privately Held (backing)

Developer of a nerve illumination technology designed to help doctors perform precision surgery. Alume Biosciences is based in La Jolla, CA and was founded in 2017. Its last reported valuation was $128 million in Jan 2023. It has raised $31.2 million across 6 recorded rounds; the latest was a $2.2 million seed round in Mar 2026.

Last reported valuation
$127.8M
Oct 2026
Priced at
—
Total raised
$31.2M
Last round
Seed Round
Mar 2026

Who backs Alume Biosciences?

10 investors
InvestorType
University of CaliforniaOther
Johnson & Johnson Innovation - JLABSOther
ALMA Life Sciences—
Biobrit—
Chrysa Mineo—
Daniel Bradbury—
National Institutes of Neurological Disorders and Stroke—
San Diego—
Small Business Innovation Research and Small Business Technology Transfer Programs—
U.S. Department of Health and Human Services—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Alume Biosciences investors

10 investors are on record for Alume Biosciences, including University of California, Johnson & Johnson Innovation - JLABS, ALMA Life Sciences and Biobrit. The seed round in Mar 2026 drew 4 investors.

Free account
More of Alume Biosciences with a free account
  • ·Watch Alume Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Alume Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View